SavedAdd your journal

Journals / Türk Kardiyoloji Derneği Arşivi / 2017 / Cilt: 45 - Sayı: 1

Gender-related differences in presentation and treatment of patients with non-valvular atrial fibrillation: results from RAMSES study

Kapak hastalığı dışı atriyum fibrilasyonu olan hastaların başvuru anındaki durumları ve verilen tedavilerin cinsiyete göre farklılıkları: RAMSES çalışması bulguları

Murat BİTEKER
Cevat KIRMA
Ahmet Çağrı AYKAN
Ezgi KALAYCIOĞLU
İsmail BOLAT
Volkan DOĞAN
Özgen ŞAFAK
Onur TAŞAR
Özcan BAŞARAN
Macit KALÇIK
Mehmet TEKİNALP
Osman BETON
Pages
16–25
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This cross-sectional, multicenter, nationwide observational study enrolled 6264 non-valvular AF (NVAF) outpatients (55.9% women) from Turkey.Results: Compared with men, women with NVAF were older (71 years [range: 65-78 years] vs. 70 years [range: 62-77 years]; p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Gender is an important feature in the management of atrial fibrillation (AF).
📊
Key Findings & Data:This study investigated gender-related differences in patients with AF in Turkey.Methods: As a part of RAMSES (ReAl-life Multicenter Survey Evaluating Stroke prevention strategies in Turkey, NCT02344901) study, information of the patients with AF who successively applied to the hospital was analyzed.
💡
Conclusion & Impact:This cross-sectional, multicenter, nationwide observational study enrolled 6264 non-valvular AF (NVAF) outpatients (55.9% women) from Turkey.Results: Compared with men, women with NVAF were older (71 years [range: 65-78 years] vs. 70 years [range: 62-77 years]; p
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Gender is an important feature in the management of atrial fibrillation (AF). This study investigated gender-related differences in patients with AF in Turkey.Methods: As a part of RAMSES (ReAl-life Multicenter Survey Evaluating Stroke prevention strategies in Turkey, NCT02344901) study, information of the patients with AF who successively applied to the hospital was analyzed. This cross-sectional, multicenter, nationwide observational study enrolled 6264 non-valvular AF (NVAF) outpatients (55.9% women) from Turkey.Results: Compared with men, women with NVAF were older (71 years [range: 65-78 years] vs. 70 years [range: 62-77 years]; p

Özet

Amaç: Cinsiyet atriyum fibrilasyonu (AF) yönetimini etkileyen önemli bir özelliktir. Bu çalışmada, Türkiye'de AF'si olan hastalarda cinsiyet ile ilişkili farklar araştırıldı.Yöntemler: RAMSES (ReAl-life Multicenter Survey Evaluating Stroke prevention strategies in Turkey, NCT02344901) çalışmasının bir parçası olarak, ardışık olarak hastaneye başvuran AF'li hastaların bilgileri incelendi. Bu kesitsel, çok merkezli, ülke çapında, gözlemsel çalışmaya Türkiye'den 6264 kapak dışı AF (KDAF) poliklinik hastası (%55.9'u kadın) alındı.Bulgular: Kapak dışı AF'si olan kadınlar erkeklerle karşılaştırıldığında daha yaşlıydı (71 [dağılım: 65-78] ve 70 [dağılım: 62-77]; p

🔖

Cite This Article

BİTEKER, M., KIRMA, C., AYKAN, A. Ç., KALAYCIOĞLU, E., BOLAT, İ., DOĞAN, V., ŞAFAK, Ö., TAŞAR, O., BAŞARAN, Ö., KALÇIK, M., TEKİNALP, M., BETON, O. (2022). Gender-related differences in presentation and treatment of patients with non-valvular atrial fibrillation: results from RAMSES study. Türk Kardiyoloji Derneği Arşivi, Cilt: 45 - Sayı: 1, 16–25. https://ajindex.com/articles/632297

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Inoue H, Fujiki A, Origasa H, Ogawa S, Okumura K, Kubota I, et al. Prevalence of atrial fibrillation in the general population of Japan: an analysis based on periodic health examination. Int J Cardiol 2009;137:102-7
  2. Flegel KM, Shipley MJ, Rose G. Risk of stroke in non-rheumatic atrial fibrillation. Lancet 1987;1:526-9
  3. Dries DL, Exner DV, Gersh BJ, Domanski MJ, Waclawiw MA, Stevenson LW. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction. J Am Coll Cardiol 1998;32:695-703
  4. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J 2012;33:2719-47
  5. January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation 2014;130:199-267
  6. Volgman AS, Manankil MF, Mookherjee D, Trohman RG. Women with atrial fibrillation: Greater risk, less attention. Gend Med 2009;6:419-32
  7. Cove CL, Albert CM, Andreotti F, Badimon L, Van Gelder IC, Hylek EM. Female sex as an independent risk factor for stroke in atrial fibrillation: possible mechanisms. Thromb Haemost 2014;111:385-91
  8. Avgil Tsadok M, Jackevicius CA, Rahme E, Humphries KH, Behlouli H, Pilote L. Sex differences in stroke risk among older patients with recently diagnosed atrial fibrillation. JAMA 2012;307:1952-8
  9. Gomberg-Maitland M, Wenger NK, Feyzi J, Lengyel M, Volgman AS, Petersen P, et al. Anticoagulation in women with non-valvular atrial fibrillation in the stroke prevention using an oral thrombin inhibitor (SPORTIF) trials. Eur Heart J 2006;27:1947-53
  10. Mosca L, Barrett-Connor E, Wenger NK. Sex/gender differences in cardiovascular disease prevention: what a difference a decade makes. Circulation 2011;124:2145-54
  11. Kim ES, Menon V. Status of women in cardiovascular clinical trials. Arterioscler Thromb Vasc Biol 2009;29:279-83
  12. Dagres N, Nieuwlaat R